Press Release: AEMH : Alvogen Issues Voluntary Nationwide Recall for One Lot of Fentanyl Transdermal System 25 mcg/h Due to a Defective Delivery System
/PRNewswire/ -- Alvogen, Inc. is voluntarily recalling one lot of Fentanyl Transdermal System 25 mcg/h transdermal patches to the consumer level. The reason...
Read full article »
Alvogen is a New Jersey-based pharmaceutical company that develops, manufactures and supplies OTC medicinal products for the healthcare industry.
Read more